01 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/01/3125763/0/en/Allogene-Therapeutics-Moves-Forward-with-Standard-Fludarabine-and-Cyclophosphamide-FC-Lymphodepletion-Regimen-in-the-ALPHA3-Trial-for-Cemacabtagene-Ansegedleucel-Cema-Cel-in-First-.html
21 Nov 2024
// ENDPTS
https://endpts.com/fda-updates-label-of-33-year-old-cancer-drug-with-new-dose-and-warning/
20 Nov 2024
// ENDPTS
https://endpts.com/fda-updates-label-of-33-year-old-cancer-drug-with-new-dose-and-warning/
27 Jun 2023
// Max Bayer FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/nkarta-touts-cell-therapy-effectiveness-specific-lymphodepletion-regiment-durability
13 Oct 2021
// Mark Terry BIOSPACE
https://www.biospace.com/article/crispr-therapeutics-announces-promising-data-for-its-car-t-cancer-therapy/?s=71
01 Sep 2021
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-1-2021-1630499458.pdf